Patents Assigned to Euroimmun Medizinische Labordiagnostika AG
-
Patent number: 12235429Abstract: An apparatus is proposed for identifying respective cover slip regions of respective cover slips having respective tissue sections on a specimen slide, which has multiple optical identifiers. The apparatus includes a planar light source, an image acquisition unit, a holding unit for positioning the specimen slide between the planar light source and the image acquisition unit, a slit diaphragm, which has multiple opening slits, reversibly positionable between the planar light source and the specimen slide, and an illumination unit, which is designed to illuminate that surface of the specimen slide which faces toward the image acquisition unit. Furthermore, the apparatus includes a monitoring unit which is designed, on the basis of a completely illuminated transmitted light image, an incident light image, and a partially darkened transmitted light image, to assign respective tissue sections to respective optical identifiers.Type: GrantFiled: December 17, 2020Date of Patent: February 25, 2025Assignee: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AGInventors: Christian Feirer, Erik Bernitt-Ringering, Martin Rateike, Simon Schwab, Winfried Stöcker
-
Patent number: 12209965Abstract: A method and apparatus are provided for detecting respective potential presences of respective different cellular fluorescence pattern types on a biological cellular substrate including human epithelioma cells (HEp cells), wherein the fluorescence pattern types include different antinuclear antibody fluorescence pattern types. A method is also provided for detecting potential presences of different cellular fluorescence pattern types on a biological cellular substrate including human epithelioma cells by means of digital image processing, as well as a computing unit, a data network device, a computer program product and a data carrier signal therefor.Type: GrantFiled: January 19, 2022Date of Patent: January 28, 2025Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Christopher Krause, Jens Krauth, Stefan Gerlach, Christian Marzahl, Melanie Hahn, Joern Voigt
-
Publication number: 20250027968Abstract: A device incubates multiple patient samples using multiple incubation vessels, including a first unit having respective receptacles for respective incubation vessels, and a second unit having respective receptacles for respective incubation vessels. Both of the respective units are each movably mounted in their respective position along a common linear guide axis, and further include respective sensors for providing respective sensor signals, each of which indicates one of the respective positions, furthermore respective magnetic drive units for a respective change of a respective position, and furthermore a control unit designed to control the respective magnetic drive units on the basis of the respective sensor signals to cause the respective changes of the respective positions.Type: ApplicationFiled: July 19, 2024Publication date: January 23, 2025Applicant: Euroimmun Medizinische Labordiagnostika AGInventors: Kolja Petter, Alexander Malzkuhn, Björn Rehm
-
Publication number: 20250027953Abstract: A method includes detecting in a sample a mammalian antibody binding specifically to ZSCAN5. A mammalian antibody binds specifically to ZSCAN5, and a carrier with a solid phase with at least one immobilized polypeptide includes at least one epitope of ZSCAN5 or a variant thereof. The mammalian antibody is used for diagnosing a neurological autoimmune disease or a cancer.Type: ApplicationFiled: May 30, 2024Publication date: January 23, 2025Applicants: EUROIMMUN Medizinische Labordiagnostika AG, Klinisch-immunologisches Labor Prof. h.c. (RCH) Dr. med. Winfried StöckerInventors: Madeleine SCHARF, Ramona Miske, Stefan Schöbel, Winfried Stöcker, Christiane Radzimski, Kathrin Borowski, Merle Corty
-
Patent number: 12174186Abstract: A method involves detecting in a sample an autoantibody binding specifically to a mammalian VGLUT. An autoantibody binding specifically to a mammalian VGLUT and a diagnostically useful carrier with a solid phase with an immobilized polypeptide containing a mammalian VGLUT or a variant thereof, are useful. The autoantibody can be used for diagnosing a neurological autoimmune disease or a cancer.Type: GrantFiled: March 25, 2022Date of Patent: December 24, 2024Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Ramona Miske, Christiane Radzimski, Kathrin Margalene Borowski, Yvonne Denno
-
Publication number: 20240353412Abstract: A method for enhancing the chemiluminescent signal of a chemiluminogenic compound in a chemiluminescent reaction mixture in a chemiluminescent reaction which has a step of oxidizing the chemiluminogenic compound in the presence of an effective amount of an enhancer can be performed. To obtain an enhanced chemiluminescent signal, a compound selected from the group of quaternary amine cationic substances of formula (I) for enhancing the chemiluminescent signal of an acridinium compound is used, preferably an acridinium ester or an acridinium sulfonamide. The signal is obtained in a chemiluminescent reaction, preferably in a chemiluminescent immunoassay, a related chemiluminescent composition and a related kit.Type: ApplicationFiled: July 21, 2022Publication date: October 24, 2024Applicant: EUROIMMUN Medizinische Labordiagnostika AGInventors: Matthias Theuser, Lars Komorowski, Antje Dammermann, Kathrin Baumert, Mareike Holste, Marcel Hinkelammert
-
Patent number: 12097493Abstract: A kit or set including a planar sample carrier having an absorbent membrane layer suitable for absorbing liquid blood components is provided, and wherein at least a portion of the blood components is able to dry in the membrane layer, wherein the sample carrier is additionally provided on an outer side with an optically readable code, additionally including a closable cuboidal box having a bottom surface that has a rectangular base surface and that additionally has a first opening, additionally including a planar receiving element having a base surface that corresponds to the base surface of the bottom surface, wherein the receiving element has a second opening and a holder that together are designed such that, on mounting the sample carrier in the holder and subsequently inserting the receiving element into the box on the bottom surface of the box, the optical code is visible through the first opening in the bottom surface and also through the second opening in the receiving element.Type: GrantFiled: July 7, 2021Date of Patent: September 24, 2024Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Thomas Pfeiffer, Stephan Proost, Lisa Honold
-
Patent number: 12083667Abstract: A method according to the invention is proposed for filtering a sensor signal, said method comprising various steps. A time-discrete sensor signal is provided as an input signal, and an output signal is generated via a continuous filtering of the input signal using a time-discrete filter in the time domain, which performs the following filter steps for each value of the input signal: comparing a specified signal value of a specified time index of the input signal with two further signal values of the input signal, wherein a first signal value of the two further signal values is temporally prior to the specified signal value and wherein a second signal value of the further signal values is temporally after the specified signal value, and replacing the specified signal value in the output signal by a new value in dependence on a value interval spanned by the two further signal values.Type: GrantFiled: December 20, 2022Date of Patent: September 10, 2024Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Felix Ahlborg, Arne Von Drathen, Siegfried Wessel
-
Publication number: 20240118209Abstract: A method is proposed for detecting at least one fluorescence pattern on an immunofluorescence image of a biological cell substrate, comprising the following steps: incubating the cell substrate with a liquid patient sample, which potentially includes primary antibodies, and furthermore with secondary antibodies, which are marked using a fluorescence stain, irradiating the cell substrate using excitation radiation and capturing the immunofluorescence image, determining segmentation information comprising at least one first and one second segmentation area, wherein the segmentation areas each represent a respective cell substrate area, via segmentation of the immunofluorescence image using a first neural network, determining a boundary area, which represents a transition from the first cell substrate area towards the second cell substrate area in the fluorescence image, on the basis of the segmentation information, selecting multiple partial images from the immunofluorescence image along the boundary area, deteType: ApplicationFiled: September 29, 2023Publication date: April 11, 2024Applicant: EUROIMMUN Medizinische Labordiagnostika AGInventors: Jens Hocke, Jens Krauth, Stefan Gerlach, Christopher Krause, Melanie Hahn, Jörn Voigt, Enno SCHMIDT, Nina VAN BEEK
-
Publication number: 20240119589Abstract: A method is proposed for detecting a presence of a fluorescence pattern on an immunofluorescence image of a biological cell substrate, comprising the following steps: incubating the cell substrate with a liquid patient sample, which potentially comprises primary antibodies, and furthermore with secondary antibodies, which are marked using a fluorescence stain, irradiating the cell substrate using excitation radiation and capturing the immunofluorescence image, determining respective items of location information, which indicate respective locations of respective relevant subsections of the cell substrate in the fluorescence image, and determining respective first partial confidence measures of respective presences of the fluorescence pattern on the respective subsections by means of a first neural network on the basis of the overall fluorescence image, extracting respective image subsections, which correspond to the respective subsections of the cell substrate, from the fluorescence image on the basis of theType: ApplicationFiled: September 22, 2023Publication date: April 11, 2024Applicant: EUROIMMUN Medizinische Labordiagnostika AGInventors: Jens KRAUTH, Jens HOCKE, Stefan GERLACH, Christopher KRAUSE, Melanie HAHN, Jörn VOIGT
-
Patent number: 11867579Abstract: A method for detecting an error state when aspirating a liquid to identify whether a pre-determined volume of liquid was aspirated. The method including: immersing a tip of an aspiration needle in the liquid, aspirating a predetermined partial volume of the liquid in the aspiration needle, continuously acquiring a sensor signal curve, which indicates a pressure in the aspiration needle, during an overall time period, detecting the error state in the case that the sensor signal falls below a first threshold value during the predetermined time period, characterized by providing a reference signal curve, determining a deviation measure, which indicates a deviation of the sensor signal curve from the reference signal curve during the further time period, providing a predetermined second threshold value, detecting the error state as a function of the deviation measure and the second threshold value.Type: GrantFiled: June 18, 2022Date of Patent: January 9, 2024Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Danny Farell, Anna Katharina Laarmann
-
Patent number: 11854191Abstract: An image processing method is provided for displaying cells from a plurality of pathology images or overall images. A respective overall image represents a respective patient tissue sample or a respective patient cell sample.Type: GrantFiled: March 2, 2021Date of Patent: December 26, 2023Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Christian Marzahl, Stefan Gerlach, Joern Voigt, Christine Kroeger
-
Patent number: 11835519Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.Type: GrantFiled: December 8, 2020Date of Patent: December 5, 2023Assignees: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and ResearchInventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat
-
Patent number: 11828758Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO: 1 or a variant thereof. The recombinant peptide may be a monomer, a dimer, or a hexamer.Type: GrantFiled: October 1, 2020Date of Patent: November 28, 2023Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
-
Patent number: 11814196Abstract: A pressure-tight storage vessel contains a liquid, has an elongated main body rotationally symmetrical with respect to an axis of symmetry, and forms, at least partially, a rotationally symmetrical hollow space in which the liquid is substantially received, wherein the main body is terminated at its bottom side by a base. Furthermore, at its top side, the storage vessel has an opening which is closed off in a pressure-tight manner by a closure, has a plurality of reinforcement elements, which bears against the main body at the outside, which extends parallel to the axis of symmetry of the main body, and arranged rotationally symmetrically about the axis of symmetry of the main body. In each case between adjacent reinforcement elements, respective externally exposed wall sections of the main body are formed, and the composition of the exposed wall sections permits a pressure-tight insertion by at least two hollow needles.Type: GrantFiled: December 18, 2019Date of Patent: November 14, 2023Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Bianca Huth, Alexander Kowtun, Lars Koschinat, Frank Mollenhauer, Winfried Stoecker
-
Publication number: 20230213534Abstract: Provide are a diagnostically useful carrier coated with a recombinant polypeptide comprising SEQ ID NO: 1, an isolated autoantibody binding specifically to a polypeptide having SEQ ID NO: 1, a kit comprising the carrier, a method for the diagnosis of a membranous nephropathy (MN) that includes detecting the presence or absence of an autoantibody binding specifically to a polypeptide having SEQ ID NO: 1 in a liquid sample comprising antibodies from a subject, a use of an autoantibody binding specifically to a polypeptide having SEQ ID NO: 1 or a polypeptide comprising SEQ ID NO: 1, and a aqueous solution comprising an autoantibody binding specifically to a polypeptide having SEQ ID NO: 1.Type: ApplicationFiled: December 2, 2021Publication date: July 6, 2023Applicant: EUROIMMUN Medizinische Labordiagnostika AGInventors: Inga-Madeleine DETTMANN, Swantje MINDORF, Christian PROBST
-
Publication number: 20230202052Abstract: A method according to the invention is proposed for filtering a sensor signal, said method comprising various steps. A time-discrete sensor signal is provided as an input signal, and an output signal is generated via a continuous filtering of the input signal using a time-discrete filter in the time domain, which performs the following filter steps for each value of the input signal: comparing a specified signal value of a specified time index of the input signal with two further signal values of the input signal, wherein a first signal value of the two further signal values is temporally prior to the specified signal value and wherein a second signal value of the further signal values is temporally after the specified signal value, and replacing the specified signal value in the output signal by a new value in dependence on a value interval spanned by the two further signal values.Type: ApplicationFiled: December 20, 2022Publication date: June 29, 2023Applicant: EUROIMMUN Medizinische Labordiagnostika AGInventors: Felix AHLBORG, Arne VON DRATHEN, Siegfried WESSEL
-
Publication number: 20230166260Abstract: An apparatus is provided for holding down membrane elements in respective wells of a multiwell plate, which has, at its top side, respective openings of the respective wells. The apparatus has, at its upper region, a support structure having respective openings, and respective corresponding retention elements which extend downwards from the respective openings of the support structure, so that respective retention elements protrude into respective wells when the support structure has been placed onto the top side of the multiwell plate. A retention element has multiple webs which extend downwards from the support structure and the ends of which are connected to one another at a bottom side of the apparatus by means of a connection element.Type: ApplicationFiled: March 10, 2022Publication date: June 1, 2023Applicant: EUROIMMUN Medizinische Labordiagnostika AGInventors: Bianca Huth, Patrick Auer, Philip Rosenstock
-
Patent number: D1052753Type: GrantFiled: February 23, 2022Date of Patent: November 26, 2024Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventor: Christian Hüwelmann
-
Patent number: D1056239Type: GrantFiled: July 28, 2021Date of Patent: December 31, 2024Assignee: EUROIMMUN Medizinische Labordiagnostika AGInventors: Torsten Grün, Tassilo Schulze